Find a TenderAwarded
Published 15 Mar 2024, 11:54 GMT

Official UK procurement notice

NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives

Official notice

Authority: NHS England (Central government)

Framework agreementGoods
Sectors: Medical Devices & Pharma (33) Delivery: UK
Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue
Awarded 1 May 2019
Framework period 4 yrs 11 moends 31 Mar 2024 · starts 1 May 2019

What is being bought

Published requirement description

No description was published on the notice. See the official documents.

CPV: Pharmaceutical products

How this framework works

From the published notice
Framework period

4 yrs 11 mo from 1 May 2019, The original advertised aim of the contract was to eliminate Hepatitis C in England. This has nearly been achieved but further services and/or supplies are necessary to achieve the elimination targets, as the last groups are harder to reach. It would not be possible to change contractor(s) for technical reasons at this stage of the programme (and no-one else can supply these medicines) and/or to do so would cause substantial inconvenience and duplication of costs.<br/>It was not foreseen that it would take longer than anticipated to get to the hard to reach groups or that the programme would be delayed due to Covid-19.<br/>The modification (i.e. extension) does not alter the overall nature of the contract as (a) the overall aim has not changed; and (b) the Authority are simply requiring more of the same supplies and services for a further two years.  <br/>The increase in costs of the modification does not exceed 50% of the original contract value.

The lotProcurement structure

single lot · no lot value published
Lot #1This procurement will be conducted by NHS Arden & Greater East Midlands Commissioning… 4 yrs 11 mo

This procurement will be conducted by NHS Arden & Greater East Midlands Commissioning Support Unit on behalf of NHS England Specialised Commissioning.<br/>Contract(s) entered into pursuant to this procurement will be between the successful supplier(s) and NHS England (National Health Service Commissioning Board).<br/>Organisations wishing to participate in the procurement must have at least one Direct Acting Antiviral (DAA) for the treatment of Hepatitis C within their product portfolio. There is no restriction on the number of DAA products that bidders can offer for, or that can be included in the contract(s).<br/>Contract(s) awarded pursuant the procurement exercise are for use by the Department of Health, Public Health England, the NHS in England; and be used by private sector contractors and agents working on behalf of the aforementioned<br/>Appointed suppliers will be responsible for (i) the supply of Hepatitis C DAA treatments and (ii) the provision of Hepatitis C elimination initiatives and/or services to help identify and treat Hepatitis C patients so as to accelerate the elimination of Hepatitis C in England from 1st October 2018. The duration of any Contract(s) awarded will be for an initial period of three (3) years, with an option to extend (at the sole discretion of the contracting authority) for an additional period or periods up to two (2) years.<br/>Further information, including details regarding the Lots, is set out in the procurement documents which are available to download (see below for details)<br/>The contracting authority intends to use the NHS Arden & Greater East Midlands Commissioning Support Unit e-procurement portal in this procurement exercise.<br/>i) To Register - log onto the portal at ardengemcsu.bravosolution.co.uk ↗ (registration and use of the website is free of charge).<br/>ii) Express interest by:<br/>a) selecting response to advert and PQQ (ref: pqq_483) and ITT (ref: itt_958)<br/>b) select Open Access ITT<br/>c) search for and access listing related to this contract and view details<br/>d) click on Express Interest link<br/>iii) Once you have expressed interest, access the My ITTs page where you can download and complete the ITT.

Contract period: 1 May 2019 – 31 Mar 2024 (4 yrs 11 mo)
Delivery: UK

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “NHS England procurement for the supply of Hepatitis C treatments and…” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
15 Mar 2024, 11:54 GMT
Last source update
15 Mar 2024, 11:54 GMT
FTS notice number
2024/S 000-008380
Classification (CPV)
Pharmaceutical products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-04490b Find a Tender

How it was run

Official notice
Appointment period ends
—

Timeline

1 May 2019 → 15 Mar 2024 · 2 dates
  1. Contract starts
    1 May 2019, 00:00 BST
  2. Notice published
    15 Mar 2024, 11:54 GMT

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • NHS England procurement for the supply of Hepatitis C treatments and the provision of Hepatitis C elimination initiatives

    Signed
    1 May 2019
    Value
    £1,200,000,000
    Period
    1 May 2019 – 31 Mar 2024
    Status
    active
    • Change Nature and extent of the modifications (with indication of possible earlier changes to the contract):<br/>The contract is to be extended for a further two years. No further modifications are to be made except for the extension in duration, Need for additional works, services or supplies by the original contractor/concessionaire: The original advertised aim of the contract was to eliminate Hepatitis C in England. This has nearly been achieved but further services and/or supplies are necessary to achieve the elimination targets, as the last groups are harder to reach. It would not be possible to change contractor(s) for technical reasons at this stage of the programme (and no-one else can supply these medicines) and/or to do so would cause substantial inconvenience and duplication of costs.<br/>It was not foreseen that it would take longer than anticipated to get to the hard to reach groups or that the programme would be delayed due to Covid-19. <br/>The modification (i.e. extension) does not alter the overall nature of the contract as (a) the overall aim has not changed; and (b) the Authority are simply requiring more of the same supplies and services for a further two years.   <br/>The increase in costs of the modification does not exceed 50% of the original contract value.

Contracting authority & participating public bodies

NHS England

Contracting authorityCentral Government 1st Floor, Quarry House, Quarry Hill, Leeds, Yorkshire & Humber, LS2 7UEContact name, email

Dispute resolution & review bodies

  • The High CourtReview body London

Framework contractors & participating bidders

1 commercial party on the notice
  • AbbVie LtdFramework contractor08004972 Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, Maidenhead, UK, SL6 4UB

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.